Morgan Stanley’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $230K | Sell |
284,382
-18,397
| -6% | -$14.9K | ﹤0.01% | 5797 |
|
|
2025
Q1 | $233K | Sell |
302,779
-62,380
| -17% | -$47.9K | ﹤0.01% | 5670 |
|
|
2024
Q4 | $466K | Buy |
365,159
+41,470
| +13% | +$52.9K | ﹤0.01% | 5443 |
|
|
2024
Q3 | $670K | Buy |
323,689
+36,335
| +13% | +$75.2K | ﹤0.01% | 5261 |
|
|
2024
Q2 | $1.09M | Sell |
287,354
-8,851
| -3% | -$33.7K | ﹤0.01% | 4902 |
|
|
2024
Q1 | $1.4M | Sell |
296,205
-301,387
| -50% | -$1.43M | ﹤0.01% | 4780 |
|
|
2023
Q4 | $2.55M | Buy |
597,592
+353,122
| +144% | +$1.51M | ﹤0.01% | 4785 |
|
|
2023
Q3 | $755K | Buy |
244,470
+49,144
| +25% | +$152K | ﹤0.01% | 4956 |
|
|
2023
Q2 | $879K | Buy |
195,326
+53,664
| +38% | +$241K | ﹤0.01% | 4909 |
|
|
2023
Q1 | $807K | Buy |
141,662
+51,713
| +57% | +$295K | ﹤0.01% | 4979 |
|
|
2022
Q4 | $543K | Sell |
89,949
-87,839
| -49% | -$531K | ﹤0.01% | 5200 |
|
|
2022
Q3 | $1.18M | Sell |
177,788
-303,000
| -63% | -$2M | ﹤0.01% | 4789 |
|
|
2022
Q2 | $2.51M | Sell |
480,788
-65,687
| -12% | -$343K | ﹤0.01% | 4357 |
|
|
2022
Q1 | $3.77M | Sell |
546,475
-299,239
| -35% | -$2.06M | ﹤0.01% | 3983 |
|
|
2021
Q4 | $10.5M | Buy |
845,714
+88,927
| +12% | +$1.11M | ﹤0.01% | 2899 |
|
|
2021
Q3 | $23.7M | Buy |
756,787
+624,622
| +473% | +$19.5M | ﹤0.01% | 1914 |
|
|
2021
Q2 | $3.78M | Buy |
132,165
+108,091
| +449% | +$3.09M | ﹤0.01% | 4074 |
|
|
2021
Q1 | $1.04M | Sell |
24,074
-3,054
| -11% | -$132K | ﹤0.01% | 4708 |
|
|
2020
Q4 | $1.94M | Buy |
27,128
+13,973
| +106% | +$1,000K | ﹤0.01% | 4183 |
|
|
2020
Q3 | $396K | Buy |
+13,155
| New | +$396K | ﹤0.01% | 4754 |
|